AI assistant
BIOLIFE SOLUTIONS INC — Director's Dealing 2021
Apr 13, 2021
32106_dirs_2021-04-12_c970d217-fc76-430a-8428-bd8ffbbc0d2b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2021-04-08
Reporting Person: Schulz Marcus (Chief Revenue Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-08 | Common Stock | S | 224 | $35.77 | Disposed | 39795 | Direct |
Footnotes
F1: The sales reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.75 to $35.78, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.